Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06885671 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Single vs Hypofractionated Irradiation For Timely Access to Partial Breast Radiotherapy

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Re-verified, no change to tracked fieldsv7
  2. Eligibility criteria shortened, about 4 wordsv6 See this version in full on ClinicalTrials.gov ↗
  3. Trial status: Not Yet Recruiting to Recruiting Start date: Jan 2026 to Jun 8, 2026 · Study sites: 0 to 1v5 Show 2 more changesShow less
    • Start date: Jan 2026 to Jun 8, 2026
    • Study sites: 0 to 1
  4. Primary and study completion dates: Jun 2027 to Dec 31, 2029 Start date: Nov 2025 to Jan 2026 · Eligibility criteria expanded, about 17 words · Secondary endpoints revised (7)v4 Show 3 more changesShow less
    • Start date: Nov 2025 to Jan 2026
    • Eligibility criteria expanded, about 17 words
    • Secondary endpoints revised (7)

    See this version in full on ClinicalTrials.gov ↗

  5. Start date: Aug 2025 to Nov 2025v3
  6. Start date: Jun 2025 to Aug 2025 Secondary endpoints: 2 to 7 · Study title shortened, about 2 wordsv2 Show 2 more changesShow less
    • Secondary endpoints: 2 to 7
    • Study title shortened, about 2 words

    See this version in full on ClinicalTrials.gov ↗

  7. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Partial Breast Irradiation (PBI) is a targeted radiation approach commonly administered post-lumpectomy, specifically targeting the tumour bed. This targeted therapy reduces the exposure to other nearby tissues such as lungs, heart, and chest wall. However, traditional PBI treatment involves lengthy multiple fraction courses which presents a burden to patients from rural and remote communities, who must travel long distances to receive high quality cancer care. The purpose of this study is to compare single fraction (SF) PBI vs. multiple fraction (MF) PBI.
Trial Details
NCT Number NCT06885671
Lead Sponsor British Columbia Cancer Agency
Conditions Breast Cancer Early Stage Breast Cancer (Stage 1-3)
Enrollment 60 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov